Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Notebook: US FDA's Paper Push, Industry Execs/US Officials Emphasize Their Collaboration

Apr 06 2020

• By Pink Sheet Team

Coronavirus map

Related Content

US FDA User Fee Renewals Remain On Schedule Despite Coronavirus

Apr 02 2020

US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Mar 29 2020

FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments

Mar 31 2020

Coronavirus Sponsors Should Get Responses To Regulatory Requests Within One Day, US FDA Says

Apr 01 2020

Coronavirus Update: Neurimmune, Ethris, Fujifilm, Brii In New Bids Against COVID-19, Reata, Ionis Delay Studies

Apr 01 2020

Related Companies

Amgen, Inc.

Genentech, Inc.

Gilead Sciences, Inc.

Regeneron Pharmaceuticals, Inc.

Additional Topics

United States Coronavirus COVID-19 FDA Manufacturing Generic Drugs Clinical Trials Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window